(Q62110241)
Statements
A Multicenter Phase 2 Study of Oral N-Acetyl Dinaline (CI-994) in the Treatment of Patients With Advanced Myeloma (English)
0 references
August 1997
0 references
February 2003
0 references
6
0 references
clinical trial